Anthem
group companies

Driven by drug discovery
          moving towards affordable biotechnology

Anthem
group companies

Driven by Drug Discovery
          moving towards affordable biotechnology

Anthem
group companies

Driven by Drug Discovery
          moving towards affordable biotechnology

Anthem
group companies

Driven by Drug Discovery
          moving towards affordable biotechnology

Anthem
group companies

Driven by Drug Discovery
          moving towards affordable biotechnology

Anthem
group companies

Driven by Drug Discovery
          moving towards affordable biotechnology

Business

Anthem Biopharma launched its products in 2010 in Indian Market. Most of our products are prescribed by leading Diabetologist, Cardiologist and Nephrologist.

Vision

Anthem's vision is of being a respected global healthcare leader. We want to provide quality products and services at affordable costs and to do this responsibly and ethically. The aim of being a diversified global healthcare is second only to the obsessive urge to establish maximum reach to patients and become the company, most admired by all our stakeholders. We believe that this will translate into sound production figures and tidy revenues.

Approach

We have embarked on a simple, yet powerful mission of positively responding to potential needs of patients globally. Our global generics business helps reduce drug costs by making generic drugs available to maximum possible number of patients, at the earliest. We will continue our quest to promote affordability and are constantly innovating to bring new, better, product concepts to patients worldwide.

Anthem is a USFDA inspected facility. The API arm of our business supplies pharmaceutical ingredients to global innovator & generic companies, which also advances our goal of providing affordable medicine.

Despite great strides in medical science, there are still many unmet medical needs, which we look to address through our proprietary products, by developing and bringing to the market new ways to deliver drugs, better pro drugs.

All in all, our aim is top class healthcare solutions by attaining the right balance of innovation and tradition, and by being a responsible business enterprise.

Anthem Biopharma has interests in four crucial areas of healthcare:

  • Cardiology (Telmidil, Telmidil H, Vestan, Lodens & Lodens F)
  • Diabetology (Metasens, Enristas, Grantin, FootSave, Tridart, Sucrazide MF, Adjuvanex, Diaplan, Terostil & Upsurge)
  • Nephrology (Keygraf, Keycept S, Vestaphilin ME, SIROtrend, CMVIgone, EPOtrend, Velvetrol, Thinaclot, Nabico3, Ketohunt & Kokino)
  • Critical Care (Anthonem, Pencilum & Peperact)
The company maintains a high ethical standard of business practice, promoting its products in a customer focuses and value-added manner, through scientific dissemination of information to the medical fraternity.

Group Companies

Anthem Biosciences, established in the year 2006 is a Bangalore based Discovery Research Alliance Partner dedicated to supporting research efforts in the discovery of new compounds by pharmaceutical, biotechnology, speciality chemicals, agriculture chemicals and material science companies.

We provide services in the area of Medicinal Chemistry, Process Chemistry, Custom Synthesis, Discovery Research and Analytical Research & Development. With its best in class infrastructure, Anthem Biosciences can do GMP synthesis from milligram to kilogram and multi-kilogram scale. Apart from modern, well equipped labs, the company has a cGMP kilo lab and a versatile GMP pilot plant.

In Discovery Research, we provide pharmaceutical clients services from generation of hits, transforming hits to leads, optimization of leads up to developable drug candidates against known or client's targets.
Accreditations
QUICK CONTACT
Name
Email ID
Contact Number
Message
CONNECT WITH US
WE ARE HERE